Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Postherpetic Neuralgia | Treatment Algorithms | Claims Data Analysis | US | 2014
Postherpetic neuralgia (PHN) is a chronic pain condition that requires prolonged treatment; this condition affected less than 246,000 people in the United States in 2013. Despite the modest size of…
Asthma (Positioning of Current and Emerging Agents) | Physician & Payer Forum | Brazil and Mexico | 2014
Several newly approved agents for asthma together with others seeking approval are expanding the range of therapeutic options for this disease in Brazil and Mexico. Drugs such as the inhaled…
Special Report: The Impact of New Iron-Based Phosphate Binders on the Hyperphosphatemia Market
A syndicated report that will provide information on various hyperphosphatemia market dynamics. It provides insight into practice patterns, attitudes and perceptions, and current and projected…
Asthma (What Are the Expectations for Optimal Positioning of New and Emerging Inhaled and Biological Therapies in Market Access Systems?) | Physician & Payer Forum | EU5 | 2014
High unmet need exists for severe, refractory asthma patients, for whom Genentech/Novartis’s Xolair is currently the only therapeutic option. Together with a number of newly approved agents for…
Venous Thromboembolism, Atrial Fibrillation, and Acute Coronary Syndrome (Novel Oral Anticoagulants in LATAM – Evolving Treatments ) | Physician & Payer Forum | Brazil and Mexico | 2014
The launch of novel oral anticoagulants (NOACs), such as Bayer/Janssen’s Xarelto, Bristol-Myers Squibb/Pfizer’s Eliquis/Elicuis, and Boehringer Ingelheim’s Pradaxa/Pradaxar, in Brazil and…
